Animal studies support this, showing that treatment with MRAs suppress inflammatory gene expression (Tnf-α, Il-6, Mcp-1, Mmp-2) and macrophage infiltration in the aortic wall and perivascular adipose tissue and reduce AAA formation.639. The gene discussed is IL6; the disease is triple-A syndrome.